当前位置：
X-MOL 学术
›
Expert Rev. Clin. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Sparsentan: the first and only non-immunosuppressive therapy for the reduction of proteinuria in IgA nephropathy
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2024-02-16 , DOI: 10.1080/1744666x.2024.2319132 Howard Trachtman 1 , Radko Komers 2 , Jula Inrig 2
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2024-02-16 , DOI: 10.1080/1744666x.2024.2319132 Howard Trachtman 1 , Radko Komers 2 , Jula Inrig 2
Affiliation
IgA nephropathy is one of the most common forms of glomerular disease. Patients with persistent proteinuria are at increased risk of progression to kidney failure. There is a significant need for s...
中文翻译：
Sparsentan：第一个也是唯一一个用于减少 IgA 肾病蛋白尿的非免疫抑制疗法
IgA 肾病是肾小球疾病最常见的形式之一。持续性蛋白尿患者进展为肾衰竭的风险增加。非常需要...
更新日期：2024-02-17
中文翻译：
Sparsentan：第一个也是唯一一个用于减少 IgA 肾病蛋白尿的非免疫抑制疗法
IgA 肾病是肾小球疾病最常见的形式之一。持续性蛋白尿患者进展为肾衰竭的风险增加。非常需要...
京公网安备 11010802027423号